---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Mitt videomöte"
developer_entity: "Capio AB (publ)"
bundle_id: "se.capio.video"
app_store_id: "1381439307"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Free"
offline_capable: false
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2026-05-28"
report_date: "2026-08-06"
last_verified: "2026-08-06T00:00:00.000Z"
report_version: "4.105.0"
total_reviews: 0
sentiment: "Excited"
sentiment_score: 65
confidence: "medium"
confidence_score: 0.5
top_praise_theme: "The platform provides a reliable and convenient way to attend remote medical consultations from home"
top_complaint_theme: "Device compatibility restrictions following the latest update prevent users from accessing necessary medical video consultations"
review_sample_size: 9
total_review_count: 9
analyzed_review_count: 9
data_age_days: 20
momentum_velocity: "maintenance"
intelligence_version: 3
tags: ["medical", "free", "excited sentiment", "mobile app", "app review", "app analysis", "patients", "capio", "healthcare"]
canonical_url: "https://marlvel.ai/apps/mitt-videomote"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# Mitt videomöte Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Free
- **Signal**: Sentiment Excited
- **Recent focus**: Device compatibility restrictions following the latest update prevent users from accessing necessary medical video consultations (top complaint) · The platform provides a reliable and convenient way to attend remote medical consultations from home (top praise)

> **TL;DR:** Mitt videomöte is a medical app by Capio AB (publ), with Excited user sentiment (65/100), available on iOS & Android.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Mitt videomöte is a medical app by Capio AB (publ).
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **User Mood** | Excited |
| **Category** | Medical |
| **Developer** | Capio AB (publ) |
| **Pricing** | Free |
| **Platforms** | iOS & Android |
| **Confidence** | Medium (0.5/1.0) |
| **Data Age** | 20d |

## Metadata & Market Performance
- **Publisher:** Capio AB (publ)
- **Category:** Medical
- **Target Audience:** Patients of Capio healthcare centers who have been scheduled for a remote video consultation by their provider.
- **Platforms:** iOS & Android
- **Version Reviewed:** 4.105.0
- **Report Date:** 2026-08-06
- **Signal Count:** 9 reviews analyzed
- **Confidence:** Medium (0.5/1.0)
- **App Store ID (iOS):** 1381439307
- **Bundle ID:** se.capio.video
- **Google Play ID:** se.capio.video
- **Performance Trend:** Stable
- **Data Window:** Analysis based on signals collected up to 2026-08-06

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Mitt videomöte is a secure video consultation app for Capio patients, structured around provider-initiated appointments on iOS and Android.
**Why users hire it:** The platform removes the administrative friction of manual scheduling by centralizing appointment management within the clinic's existing patient-care workflow.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Standard] Encrypted Video Consultations:** Secure, encrypted video calling interface for remote medical appointments.
  * *User Intent:* Users prioritize data protection and trust in the platform.
- **[Differentiator] Provider-Initiated Booking:** Video call scheduling managed exclusively by the clinic, preventing direct patient-initiated booking.
  * *User Intent:* Users seek enhanced value through premium features.
- **[Standard] Automated Appointment Reminders:** Push notifications confirming bookings and reminding users of upcoming video calls.
  * *User Intent:* Users want timely prompts to stay engaged without missing updates.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Mitt videomöte operates as a closed-loop clinical tool for Capio patients, with zero public store ratings and a maintenance-mode update cadence of approximately 69 days. The lack of public engagement metrics reflects its status as a utility for existing patients rather than a growth-focused consumer product.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Free
- **Tiers:** Free to download and use as part of existing healthcare services
- **Analysis:** The app functions as a free utility for existing patients to access care, with no direct consumer monetization.

<!-- section:sentiment -->
## 🟢 User Sentiment (Medium Confidence: 9 of 9 reviews analyzed) {#user-sentiment}
- **Overall Sentiment:** Excited

### Top Praises
- **The platform provides a reliable and convenient way to attend remote medical consultations from home**
- **Clear interface design allows users to join meetings without technical issues regarding audio or video**

### Top Complaints (Impact Areas)

- **Device compatibility restrictions following the latest update prevent users from accessing necessary medical video consultations**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Encrypted video architecture ensures medical privacy compliance

**Growth Levers:**
- Authentication recovery flows could resolve international login failures


<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

Technical regressions regarding device compatibility and international authentication persist without remediation, maintaining the app's status in a maintenance-only cycle. The core competitive position remains unchanged as the developer continues to prioritize clinical control over consumer-facing feature expansion.

**Overall trend**: Stable
**Compared at**: 2026-08-06

### Medium-impact changes
- **[Shifted] Refined SWOT focus** (swot)

### Low-impact changes
- **[Shifted] Strategic positioning update** (positioning)

<!-- section:whats-new -->
## What's New

- **Latest (v4.105.0, 2 months ago):** Routine design refinements and bug fixes.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Ships minor bug fixes only.
- Maintenance-mode update cadence.

> **Cadence:** 2 total versions · 0 majors in last 6 months · 69 days since last update · 42 days avg between updates

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Mitt videomöte is a market-leading medical app that is completely free.

<!-- speakable-start -->
> **Bottom Line:** Restoring device compatibility and authentication stability is essential, as these technical regressions currently prevent patients from accessing their scheduled care. Addressing these failures will stabilize the platform's utility for the existing patient base.
<!-- speakable-end -->

**Best for:** Patients of Capio healthcare centers who have been scheduled for a remote video consultation by their provider.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] Audit device compatibility logic in the latest release because user reports indicate widespread access blocks → restore service for affected patients
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Declining

The outlook for Mitt videomöte is declining due to persistent technical friction that directly impedes the delivery of medical services. Without a shift from maintenance to active bug remediation, the platform risks losing its role as a viable remote care channel for Capio patients.

- 🔴 Technical regressions in the latest release (device blocks, login failures) erode the core utility of the app, forcing patients to seek alternative care channels.
- ⚪ The maintenance-only release cadence suggests limited engineering capacity, which complicates the resolution of complex authentication and compatibility bugs.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Total Reviews | 0 |
| Sentiment | Excited (65/100) |
| Confidence | Medium |
| Pricing Model | Free |
| Platforms | iOS & Android |
| Key Features | 3 analyzed |
| Trend | Stable |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Mitt videomöte** (this app) | N/A/5 | Excited | Capio AB (publ) |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** Capio AB (publ)
- **Website:** [https://capio.se](https://capio.se)
- **Social:** [Instagram](https://www.instagram.com/capiosverige) · [Facebook](https://www.facebook.com/capiosverige) · [LinkedIn](https://www.linkedin.com/company/capio-sverige)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/mitt-videom%C3%B6te/id1381439307?uo=4)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=se.capio.video&hl=en&gl=us)
- **Dev Site:** [Official Website](https://capio.se)
- **Sources:** Developer website content, App store metadata, User reviews.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating
- [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating
- [*2nd.MD*](https://marlvel.ai/apps/2nd-md) (Accolade, Inc.) · 4.9/5 Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.5/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 9
- **Data Sources:** user reviews, developer website, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 20 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/mitt-videomote)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.